Nestlé agrees $2.6bn deal for Aimmune Therapeutics

Consumer goods group pushes further into food allergy prevention with purchase of biopharmaceutical company
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news